Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04055350
Other study ID # R20007R
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date June 30, 2022

Study information

Verified date December 2021
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

National early warning score (NEWS) enables early detection of patient deterioration in hospital floors. However, there is limited data on the prognostic value of NEWS among actual general ward patients. Further, there is no data on how changes in NEWS-values impact patient outcomes. Very little is known on how post-operative nausea and vomiting (PONV) and pain influences NEWS values and vital signs in general.


Description:

The investigators aim to collect detailed data on patients' vital signs, NEWSs, pain scores and PONV scores through electronic data records, where these values are automatically stored with mobile mobile smart devices used by nursing staff. The expected volume of the cohort is 50,000 patients and 300,000 recordings of vital signs. In addition to the scores and vital signs, the registry will include patients' identification numbers (IDs), dates and times of the recordings, and ward numbers. With the IDs, mortality data up to 90-days for the patients will be obtained from the national population register centre. All data will be handled in a pseudonymized form in a secure computer inside hospital, and approval to use the registry in study purposes will be obtained from the Ethics Committee of Tampere University Hospital.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30000
Est. completion date June 30, 2022
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult in-hospital patients with recordings of vital signs Exclusion Criteria: - Patients under 18 years

Study Design


Related Conditions & MeSH terms

  • Prevention of In-hospital Adverse Events

Locations

Country Name City State
Finland Tampere University Hospital Tampere Pirkanmaa

Sponsors (1)

Lead Sponsor Collaborator
Tampere University Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Death occurring within 90-days of the last NEWS measurement The percentage of patients that die within 90-days of the last NEWS recording during their hospitalization. 90 days
Primary Death occurring within one day after the first NEWS measurement on general wards The percentage of patients that die within one day after their first NEWS measurement at the beginning of their general ward admission One day
Secondary Death occurring within 30-days of the last NEWS measurement The percentage of patients that die within 30-days of the last NEWS recording during their hospitalization. 30 days
Secondary Death occurring within 2-30 days after the first NEWS measurement on general wards The percentage of patients that die within 2-30 days after their first NEWS measurement at the beginning of their general ward admission 2-30 days
Secondary Incidence of post operative nausea and vomiting Percentage of patients suffering from post-operative nausea and vomiting (recorded as a scale from 0 to 5) in the electronic patient records. Up to 30 days after the first recording of patient's vital signs in the electronic patient records
Secondary Incidence of post operative pain Percentage of patients suffering from post operative pain (recorded as numerical scale from 0 to 10) in the electronic patient records. Up to 30 days after the first recording of patient's vital signs in the electronic patient records